<--GAT-->
Clinical Topics

Increasing Usage of SSRIs for Dementia Symptoms

by U.S. Medicine

November 29, 2018

DALLAS—Emerging data has suggested effectiveness for selective serotonin reuptake inhibitors for treatment of behavioral and psychological symptoms of dementia.

That is why clinicians now sometimes opt to use SSRIs instead of off-label antipsychotics, a traditional treatment for the condition, according to a study in The Mental Health Clinician.

Researchers from the VA North Texas Healthcare System and Texas Tech University Health Sciences Center sought to evaluate the prevalence of antipsychotic discontinuation six months after SSRI initiation for the treatment of BPSD.

Included in the study were 36 patients with Alzheimer dementia who were prescribed an antipsychotic and later prescribed an SSRI for BPSD during Jan. 1, 2009, through Dec. 30, 2014. Exclusions include those with (1) a dementia diagnosis other than Alzheimer; (2) scheduled benzodiazepines, mood stabilizers, or non-SSRI antidepressant use during the study period; (3) diagnoses of bipolar or psychotic disorders; and (4) diagnosis of delirium during the study period.

Researchers collected patients’ age, sex, race and functional assessment of staging for Alzheimer disease scores were collected, while also recording types, dosages and discontinuation dates of SSRIs and antipsychotics.

The study team reported that, Overall, antipsychotic use was reduced in 11 patients (30.6%). Another 10 patients (27.8%) discontinued the antipsychotic, and one additional patient had a reduction in dose. When comparing specific SSRIs, 8 (72%) responders were prescribed citalopram, and 15 (60%) nonresponders were prescribed sertraline.

“Approximately 30% of patients with Alzheimer dementia who were prescribed antipsychotics for BPSD were able to discontinue the medication or had a dose reduction after starting SSRI therapy. Most SSRI responders were prescribed citalopram,” study authors pointed out.

1. Mathys M, Fang S, John J, Carter J. Antipsychotic discontinuation after the initiation of selective serotonin reuptake inhibitors therapy for the treatment of behavioral and psychological symptoms associated with dementia. Ment Health Clin. 2018 Apr 26;8(3):122-126. doi: 10.9740/mhc.2018.05.122. eCollection 2018 May. PubMed PMID: 29955557; PubMed Central PMCID: PMC6007639.



Related Articles

Better Survival for NSCLC Patients Treated by Military Medicine

Does universal healthcare access provided by the MHS translate into improved patient outcomes for non-small cell lung cancer?

PhARMD Program Continues to Expand Pharmacists’ Clinical Role in VA

A tool developed by the VA has raised the profile of pharmacists as critical members of patient care teams at the VA, leading to a doubling of the number of pharmacists serving as providers.


U.S. Medicine Recommends


More From neurology

Neurology

Rural Veterans With MS Benefit from Clinical Video Telehealth Rehabilitation

Of the more than 28,000 veterans with multiple sclerosis (MS) who receive care at the VHA, almost 45% of them live in rural or highly rural areas, a recent conference presentation pointed out.

Neurology

Algorithm Proposed to Improve Detection of MS Lesions

Magnetic resonance imaging (MRI) is considered crucial for in vivo detection and characterization of white matter lesions (WMLs) in multiple sclerosis.

Neurology

Many Survey Respondents Say Marijuana Is Good for MS

Despite insufficient evidence regarding its risks and benefits, marijuana is increasingly available and aggressively marketed to the public, according to a new study which sought to understand the public's views on the risks and benefits of marijuana use.

Neurology

Even Mild TBI Can Dramatically Increase Risk of Developing Parkinson's Disease

Mild traumatic brain injury, commonly known as concussion, appears to increase a patient's risk of developing Parkinson's disease by as much as 56%, a new veterans study found.

Neurology

Even mild TBI increases veterans' dementia risk

The risk of dementia is increased even in veterans who suffer mild traumatic brain injury (TBI) without loss of consciousness.

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up